Impact of 5‐ASA discontinuation in children with ulcerative colitis on biologic therapy: A propensity score‐matched study
5-ASA discontinuation might negatively impact the clinical course of children with UC treated with anti-TNF. Considering the good safety profile of the drug, continuing mesalamine can be suggested as a prudent approach.
Authors
- Mara Corpino
- Maria Teresa Fioretti (ORCID: https://orcid.org/0000-0002-2437-3237)
- Giulia Mancuso
- Luca Scarallo (ORCID: https://orcid.org/0000-0003-1056-4400)
- Maria Teresa Illiceto
- L. Norsa
- Serena Arrigo (ORCID: https://orcid.org/0000-0002-5564-7018)
- Giovanna Zuin (ORCID: https://orcid.org/0009-0006-0404-4977)
- Giulia D'Arcangelo
- Matteo Bramuzzo
- Marina Aloi
- Claudio Romano
- Paolo Lionetti
Institutions
- University of Messina (IT)
- University of Milan (IT)
- IRCCS Materno Infantile Burlo Garofolo (IT)
- Istituto Giannina Gaslini (IT)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- Ospedale Papa Giovanni XXIII (IT)
- Ospedale di Santo Spirito (IT)
- Azienda Ospedaliera San Gerardo (IT)
- Meyer Children's Hospital (IT)
- Federico II University Hospital (IT)
- Ospedale Microcitemico (IT)
- Ospedale dei Bambini Vittore Buzzi (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- University of Naples Federico II (IT)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Journal of Pediatric Gastroenterology and Nutrition
- Published
- 2026-03-26
- DOI
- https://doi.org/10.1002/jpn3.70415
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00